STAAR Surgical Company
STAA
$18.03
$0.150.84%
NASDAQ
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Revenue | 48.95M | 88.59M | 99.01M | 77.36M | 76.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.95M | 88.59M | 99.01M | 77.36M | 76.27M |
| Cost of Revenue | 17.30M | 20.10M | 20.59M | 16.32M | 15.55M |
| Gross Profit | 31.65M | 68.49M | 78.41M | 61.04M | 60.73M |
| SG&A Expenses | 47.45M | 48.24M | 52.39M | 49.87M | 38.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.80M | 82.84M | 87.04M | 79.57M | 64.41M |
| Operating Income | -27.85M | 5.75M | 11.96M | -2.22M | 11.86M |
| Income Before Tax | -30.33M | 13.16M | 10.33M | -2.21M | 13.74M |
| Income Tax Expenses | 3.89M | 3.18M | 2.96M | 1.13M | 5.98M |
| Earnings from Continuing Operations | -34.23M | 9.98M | 7.38M | -3.34M | 7.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.23M | 9.98M | 7.38M | -3.34M | 7.76M |
| EBIT | -27.85M | 5.75M | 11.96M | -2.22M | 11.86M |
| EBITDA | -25.47M | 7.51M | 13.49M | -979.00K | 13.07M |
| EPS Basic | -0.69 | 0.20 | 0.15 | -0.07 | 0.16 |
| Normalized Basic EPS | -0.38 | 0.17 | 0.13 | -0.03 | 0.19 |
| EPS Diluted | -0.69 | 0.20 | 0.15 | -0.07 | 0.16 |
| Normalized Diluted EPS | -0.38 | 0.17 | 0.13 | -0.03 | 0.19 |
| Average Basic Shares Outstanding | 49.27M | 49.20M | 49.13M | 48.91M | 48.82M |
| Average Diluted Shares Outstanding | 49.27M | 49.73M | 49.81M | 48.91M | 49.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |